Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating subcutaneous Kisspeptin in patients with hypothalamic amenorrhea, including those with hypogonadotropic hypogonadism, and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kisspeptin (Kisspeptin)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism | Phase 2 | Status: RECRUITING